Time-dependent impact of diabetes on mortality in patients with stroke: Survival up to 5 years in a health insurance population cohort in Germany

Diabetes Care

Volumn 35, Issue 9, 2012, Pages 1868-1875

  Icks, Andrea ^a   Glaeske, Gerd ^c   Claessen, Heiner ^a   Hoffmann, Falk ^c   Morbach, Stephan ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Leibniz Center for Diabetes Research ^*  (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG USE; FEMALE; GERMANY; HEALTH INSURANCE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SURVIVAL RATE; TIME;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; GERMANY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; STROKE; TIME FACTORS;

EID: 84865527651     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2159     Document Type: Article

References (40)

1. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011;34(Suppl. 1):11-61
2. Icks A, Scheer M, Genz J, Giani G, Glaeske G, Hoffmann F. Stroke in the diabetic and non-diabetic population in Germany: relative and attributable risks, 2005-2007. J Diabetes Complications 2011;25:90-96
3. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004;164:1422-1426
4. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-1623
5. Mulnier HE, Seaman HE, Raleigh VS, et al. Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia 2006;49:2859-2865
6. Zhang Y, Galloway JM, Welty TK, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation 2008;118:1577-1584
7. Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke 2006;37:1674-1679
8. Hart CL, Hole DJ, Smith GD. Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke 2000;31:1893-1896
9. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50:208-216
10. Rautio A, Eliasson M, Stegmayr B. Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects: findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003. Stroke 2008;39:3137-3144
11. Kamalesh M, Shen J, Eckert GJ. Long term postischemic stroke mortality in diabetes: a veteran cohort analysis. Stroke 2008;39: 2727-2731
12. Winell K, Pääkkönen R, Pietilä A, Reunanen A, Niemi M, Salomaa V. Prognosis of ischaemic stroke is improving similarly in patients with type 2 diabetes as in non-diabetic patients in Finland. Int J Stroke 2011;6:295-301
13. Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant 2011;26:1634-1640
14. Icks A, Scheer M, Morbach S, et al. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care 2011;34:1350-1354
15. Icks A, Haastert B, Genz J, et al. Time-dependent impact of diabetes on the mortality of patients on renal replacement therapy: a population-based study in Germany (2002-2009). Diabetes Res Clin Pract 2011;92:380-385
16. Hatano S. Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ 1976;54:541-553
17. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia 2006;49:1498-1504
18. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-864
19. Bartholomeyczik S, Hunstein D. Time distribution of selected care activities in home care in Germany. J Clin Nurs 2004;13:97-104
20. Schäfer I, von Leitner EC, Schön G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS ONE 2010;5:e15941
21. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526
22. Machin D, Cheung YB, Parmar MKB. Survival Analysis: A Practical Approach. 2nd ed. Chichester, U.K., John Wiley & Sons, 2005
23. Vandenbroucke JP, von Elm E, Altman DG, et al.; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297
24. Arbeitsgruppe Erhebung und Nutzung von Sekundärdaten der Deutschen Gesellschaft für Sozialmedizin und Prävention; Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie; Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie; Deutschen Gesellschaft für Sozialmedizin und Prävention. Good practice of secondary data analysis, first revision. Gesundheitswesen 2008;70:54-60 [in German]
25. Schäfer I, Küver C, Gedrose B. Selection effectsmay account for better outcomes of the German Disease Management Program for type 2 diabetes. BMCHealth Serv Res 2010;10:351
26. Rossnagel K, Jungehülsing GJ, Nolte CH, et al. Out-of-hospital delays in patients with acute stroke. Ann Emerg Med 2004;44:476-483
27. Gargano JW, Wehner S, Reeves MJ. Do presenting symptoms explain sex differences in emergency department delays among patients with acute stroke? Stroke 2009;40:1114-1120
28. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 2009;40:2068-2072
29. Asplund K, Hägg E, Helmers C, Lithner F, Strand T, Wester PO. The natural history of stroke in diabetic patients. Acta Med Scand 1980;207:417-424
30. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005;23:1217-1223
31. Yatsuya H, Folsom AR, Yamagishi K, North KE, Brancati FL, Stevens J; Atherosclerosis Risk in Communities Study Investigators. Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010;41:417-425
32. Vemmos K, Ntaios G, Spengos K, et al. Association between obesity andmortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011;42:30-36
33. Towfighi A, Ovbiagele B. The impact of body mass index onmortality after stroke. Stroke 2009;40:2704-2708
34. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53
35. Idris I, Hill R, Sharma JC. Effects of admission serum urea, glomerular filtration rate, proteinuria and diabetes status on 3-month mortality after acute stroke. Diab Vasc Dis Res 2010;7:239-240
36. Gunarathne A, Patel JV, Potluri R, et al. Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract 2008;62:197-201
37. Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results of the Bertelsmann Health-Care Monitor. Gesundheitswesen 2012:74;291-297 [in German]
38. Hoffmann F, Icks A. Diabetes prevalence based on health insurance claims: large differences between companies. Diabet Med 2011;28:919-923
39. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. A prospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998;29:2501-2506
40. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735-2740